Tech Center 3700 • Art Units: 3741
This examiner grants 80% of resolved cases
Rene D. Ford is an examiner in Tech Center 3700 and Art Unit 3741. She has reached a resolution in 457 cases. The data shows an allowance rate of 80.1 percent for these applications. This high percentage indicates that four out of every five cases resolved by this examiner result in a patent grant. Practitioners can use this 80.1 percent figure to assess the favorable environment for applicants when their cases are assigned to this profile.
The effectiveness of interviews is reflected in an interview lift of 22.2 percent. This metric suggests that engaging in direct dialogue with the examiner provides a significant increase in the probability of allowance. An interview lift of 22.2 percent indicates that verbal communication is a highly effective supplement to written prosecution for resolving outstanding issues. Practitioners should consider scheduling an interview to capitalize on this positive correlation with successful outcomes.
The median days to allowance for cases handled by this examiner is 1034. This timeline represents the middle value of the duration from filing to grant. A median of 1034 days provides a specific benchmark for applicants to use when planning their prosecution strategy. These metrics are grounded in 457 resolved cases, offering a reliable perspective on the examiner's historical trends and performance.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19130235 | AIR INLET INTENDED TO BE CONNECTED TO A FAN CASING OF A TURBINE ENGINE BY A FLANGE-TYPE ASSEMBLY AND PROPULSION ASSEMBLY COMPRISING A TURBINE ENGINE EQUIPPED WITH SUCH AN AIR INLET | Non-Final OA | SAFRAN NACELLES |
| 19225706 | GAS TURBINE ENGINE WITH BYPASS TOBI COOLING/PURGE FLOW AND METHOD | Non-Final OA | RTX Corporation |
| 19131710 | HEAT SHIELD WITH RECESSED DUAL-EXPANSION NOZZLE, AND VEHICLE INCLUDING THE SAME | Final Rejection | STOKE Space Technologies, Inc. |
| 18287069 | Electronic System for a Drug Delivery Device | Final Rejection | Sanofi |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy